Paper of the Month - October, 2012

0 rating

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.

Sands BE, Katz S, Wolf DC et al.
Editor's note: Granulocyte and monocytes contribute to the pathogenesis of inflammatory bowel disease (IBD) by secreting proteases and proinflammatory cytokines, including tumor necrosis factor (TNF), interleukin-1β (IL-1β), and IL-6 that induce and maintain mucosal inflammation. Apheresis can selectively deplete activated granulocytes and monocytes.


READER POLL

Gastro 1
When treating a pediatric patient with newly diagnosed, mild Crohn’s disease, do you prefer to treat with:






Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE